Biblio

H. Schedel, Quaedflieg, P. J. L. M., Broxterman, Q. B., Bisson, W. H., Duchateau, A. L. L., Maes, I. C. H., Herzschuh, R., and Burger, K., “Synthesis of (R)-4, 4, 4-trifluoro-2-mercaptobutyric acid”, Tetrahedron: Asymmetry, vol. 11, pp. 2125–2131, 2000.

J. D. Chavez, Bisson, W. H., and Maier, C. S., “A targeted mass spectrometry-based approach for the identification and characterization of proteins containing $\alpha$-aminoadipic and $\gamma$-glutamic semialdehyde residues”, Analytical and bioanalytical chemistry, vol. 398, pp. 2905–2914, 2010.

A. K. Ehrlich, Pennington, J. M., Bisson, W. H., Kolluri, S., and Kerkvliet, N. I., “TCDD, FICZ, and other high affinity AhR ligands dose-dependently determine the fate of CD4+ T cell differentiation.”, Toxicol Sci, 2018.

C. A. Larsen, Dashwood, R. H., and Bisson, W. H., “Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance”, Pharmacological Research, vol. 62, pp. 457–464, 2010.

C. A. Larsen, Bisson, W. H., and Dashwood, R. H., “Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies”, Journal of medicinal chemistry, vol. 52, pp. 6543–6545, 2009.

W. H. Bisson, Amedei, A., Memeo, L., Forte, S., and Felsher, D. W., “Tumor-Promoting/Associated Inflammation and the Microenvironment: A State of the Science and New Horizons”, Hoboken, NJ, USA: John Wiley & Sons, Inc., 2018, pp. 473 - 510.